Toby Maher (St. Albans, Hertfordshire, United Kingdom), Bruno Crestani (Paris, France)
LATE-BREAKING ABSTRACT: Anti-fibrotic effects of nintedanib and pirfenidone in 2D versus 3D lung cultures Mareike Lehmann (München, Germany), Mareike Lehmann, Lara Buhl, Darcy Wagner, Jürgen Behr, Michael Lindner, Melanie Königshoff
| |
Induction of pro-fibrotic biomarkers in precision-cut lung slices (PCLS) Christina Hesse (Hannover, Germany), Christina Hesse, Samuel Mang, Heinz-Gerd Hoymann, Monika Niehof, Peter Braubach, Danny Jonigk, Gregor Warnecke, Olaf Pfennig, Hans-Gerd Fieguth, Armin Braun, Katherina Sewald
| |
The role of miR-21 and miR-34a in the fibrotic process of the lung Federica Meloni (Pavia, Italy), Patrizia Morbini, Elena Rossi, Simona Inghilleri, Giuseppina Ferrario, Davide Piloni, Salvatore Cuzzocrea, Rosanna Di Paola, Fiorella Calabrese, Bart Vanaudenaerde, Federica Meloni
| |
Germline SFTPA1 mutation in familial idiopathic interstitial pneumonia and lung cancer Nadia Nathan (Paris, France), Nadia Nathan, Violaine Giraud, Clément Picard, Hilario Nunes, Florence Dastot Le Moal, Philippe Duquesnoy, Bruno Copin, Martine Reynaud Gaubert, Dominique Valeyre, Louis-Jean Couderc, Thierry Chinet, Raphaël Borie, Bruno Crestani, Valérie Nau, Sylvie Tissier, Laurie Galeron, Alice De Ligniville, Nathalie Kuziner, Maud Simansour, Lamisse Mansour Hendili, Marie Legendre, Caroline Kannengiesser, Aurore Coulomb, Laurent Gouya, Serge Amselem, Annick Clement
| |
Pirfenidone attenuates myofibroblast differentiation during insufficient mitophagy Yusuke Kurita (Tokyo, Japan), Yusuke Kurita, Jun Araya, Hiromiti Hara, Shunsuke Minagawa, Nayuta Saito, Nahoko Sato, Kazuya Tubouchi, Masahiro Yoshida, Kenji Kobayashi, Takanori Numata, Yumi Kaneko, Katutoshi Nakayama, Kazuyoshi Kuwano
| |
Mechanisms of treatment response to pirfenidone of idiopathic pulmonary fibrosis (IPF) patients Nicola Ronan (Cork, Ireland), Nicola Ronan, Kashif A. Khan, Abirami Subramaniam, Yvonne McCarthy, Louise Burke, A. Chelliah, Barry J. Plant, Michael T. Henry
| |
Safety and efficacy of pirfenidone in patients with lung fibrosis and TERT mutation Aurélien Justet (Villemomble, France), Aurélien Justet, Raphael Borie, Hilario Nunes, Vincent Cottin, Sylvain Marchand Adam, Jacques Cadranel, Emmanuel Bergot, Lidwine Wemeau-Stervineau, Jean Marc Naccache, Eline Magois, Irene Frachon, Anne Gondouin, Anas Medhaoui, Jean Francois Cordier, Dominique Valeyre, Bernard Grandchamp, Caroline Kanengiesser, Bruno Crestani
| |
Metabolic shift during TGF- β-induced collagen synthesis Brintha Selvarajah (London, United Kingdom), Brintha Selvarajah, Ilan Azuelos, Ellen Forty, Manuela Plate, Dimitris Anastasiou, Paul Mercer, Rachel Chambers
| |